{
    "eid": "2-s2.0-85163814996",
    "title": "An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA",
    "cover-date": "2023-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Payuda Hansoongnern",
        "Pornpitra Pratedrat",
        "Pornjarim Nilyanimit",
        "Rujipat Wasitthankasem",
        "Nawarat Posuwan",
        "Nasamon Wanlapakorn",
        "Kanchanok Kodchakorn",
        "Prachya Kongtawelert",
        "Napaporn Pimsing",
        "Yong Poovorawan"
    ],
    "citedby-count": 0,
    "ref-count": 29,
    "ref-list": [
        "Overview of hepatitis C infection, molecular biology, and new treatment",
        "Sofosbuvir-velpatasvir: A single-tablet treatment for hepatitis C infection of all genotypes",
        "Global elimination of chronic hepatitis",
        "Serological evidence of hepatitis A, B, and C virus infection in older adults in Khon Kaen, Thailand and the estimated rates of chronic hepatitis B and C virus infection in Thais, 2017",
        "Decreasing hepatitis C virus infection in Thailand in the past decade: evidence from the 2014 national survey",
        "Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: an economic evaluation and budget impact analysis",
        "Utility of hepatitis C virus core antigen testing for diagnosis and treatment monitoring in HCV infection: a study from India",
        "Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients",
        "Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results",
        "Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy",
        "The correlation of HCV RNA and HCV core antigen in different genotypes of HCV",
        "HCV core antigen is a useful predictor during pegylated-interferon/ ribavirin therapy in patients with hepatitis C virus genotype 1b",
        "Hepatitis C virus core antigen: a simplified treatment monitoring tool, including for post-treatment relapse",
        "Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples",
        "Hepatitis C virus: virology, diagnosis and treatment",
        "Hepatitis C viral life cycle",
        "Hepatitis C virus core mutations associated with false-negative serological results for genotype 3a core antigen",
        "Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand",
        "Prevalence of hepatitis C virus in an endemic area of Thailand: burden assessment toward HCV elimination",
        "ClustalWand Clustal X version 2.0",
        "Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C",
        "Hepatitis C core antigen: diagnosis and monitoring of patients infected with hepatitis C virus",
        "HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs",
        "Sequence analysis of the core gene of 14 hepatitis C virus genotypes",
        "Evaluation of hepatitis C virus core antigen assays in detecting recombinant viral antigens of various genotypes",
        "Hepatitis C virus mutations reduce the sensitivity of a fluorescence enzyme immunoassay",
        "Bioinformatics analysis of domain 1 of HCV-core protein: Iran",
        "Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assays"
    ],
    "affiliation": [
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60032250",
            "affilname": "Faculty of Medicine, Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032250",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60004391",
            "affilname": "Thailand National Science and Technology Development Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004391",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phetchabun",
            "@id": "117924993",
            "affilname": "Phetchabun Provincial Health Office",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117924993",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "101823394",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101823394",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}